For the second quarter in a row, Propecia sexual dysfunction lawsuits have grown at a double-digit rate, according to a Nov.11 report in the Examiner. The drugmaker’s quarterly report for the period ending Sept. 30 revealed that approximately 265 claims of persistent Propecia sexual side effects had been brought by 415 plaintiffs.

Since the last quarter ended three months earlier on Jun. 31, that represents a 32.5 percent rise in lawsuits, and a 27.5 percent rise in plaintiffs.

But perhaps the most substantial loss for Merck & Co. can be felt in its financial sector. Profits for the period ending Sept. 30 fell 7 percent to $104 million, when last year at that time, the finasteride drug earned the company $112 million.

It may not be a coincidence that in July 2012, which was around the time of these financial drop-offs and mounting Propecia sexual dysfunction lawsuits, the results of a study on Propecia sexual side effects was published in the Journal of Sexual Medicine. Findings revealed that patients who experienced Propecia sexual dysfunction continued to do so three months after they stopped taking the drug.

And it gets worse: of the 54 men under age 40 who were surveyed, researchers at George Washington University discovered that 96 percent were still experiencing a low libido, erectile dysfunction, penile shrinkage and other Propecia sexual side effects more than a year later.

Since Propecia was approved the Food and Drug Administration (FDA) in 1997, it is estimated that the agency has received more than 400 adverse event reports of sexual dysfunction associated with the drug. About 60 of those complaints were filed by patients who were still experiencing Propecia sexual dysfunction side effects more than three months after they stopped taking the medication.

Published December 6, 2012 by